.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,947,295

« Back to Dashboard

Claims for Patent: 7,947,295

Title:Ophthalmic compositions containing a synergistic combination of two polymers
Abstract: Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of two polymers that have a synergistic effect on viscosity.
Inventor(s): Chowhan; Masood A. (Arlington, TX), Chen; Huagang (Arlington, TX)
Assignee: Alcon, Inc. (Hunenberg, CH)
Application Number:11/673,070
Patent Claims: 1. An aqueous composition suitable for ophthalmic administration comprising a viscosity enhancing amount of combination of two polymers having a synergistic effect on the composition's viscosity and wherein the combination of two polymers is selected from the group consisting of hydroxypropyl methylcellulose and guar gum; a carboxyvinyl polymer and guar gum; and hyaluronic acid and guar gum, provided that if the composition comprises a carboxyvinyl polymer then the composition does not contain sodium chloride or boric acid wherein the total concentration of the two polymers ranges from 0.05-3.0% (w/w); wherein the viscosity of the composition is greater than 150% of the simple sum of two respective single polymer solutions containing only one of the two polymers.

2. The composition of claim 1 wherein the combination of two polymers is a combination of a hydroxypropyl methylcellulose and guar gum.

3. The composition of claim 1 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum.

4. The composition of claim 1 wherein the combination of two polymers is a combination of hyaluronic acid and guar gum.

5. The composition of claim 3 wherein the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol, the hydroxypropyl methylcellulose has a number average molecular weight of approximately 86,000 dalton, the guar gum is hydroxypropyl guar, and the hyaluronic acid is sodium hyaluronate.

6. The composition of claim 1 wherein the total concentration of the two polymers ranges from 0.2-2.0% (w/w).

7. The composition of claim 1 further comprising an ingredient selected from the group consisting of pharmaceutically acceptable buffering agents; preservatives; tonicity-adjusting agents; surfactants; solubilizing agents; stabilizing agents; comfort-enhancing agents; emollients; pH-adjusting agents; and lubricants.

8. The composition of claim 1 further comprising an ophthalmic drug.

9. The composition of claim 8 wherein the ophthalmic drug is selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.

10. An aqueous composition suitable for ophthalmic administration comprising: an ophthalmic drug; and a viscosity enhancing amount of combination of two polymers having a synergistic effect on the composition's viscosity and wherein the combination of two polymers is selected from the group consisting of hydroxypropyl methylcellulose and guar gum; a carboxyvinyl polymer and guar gum; and hyaluronic acid and guar gum; wherein the total concentration of the two polymers ranges from 0.2-2.0% (w/w); wherein the viscosity of the composition is greater than 150% of the simple sum of two respective single polymer solutions containing only one of the two polymers.

11. The composition of claim 10 provided that if the composition comprises a carboxyvinyl polymer then the composition does not contain sodium chloride or boric acid.

12. The composition of claim 10 wherein the combination of two polymers is a combination of a hydroxypropyl methylcellulose and guar gum.

13. The composition of claim 10 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum.

14. The composition of claim 10 wherein the combination of two polymers is a combination of hyaluronic acid and guar gum.

15. The composition of claim 13 wherein the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol, the hydroxypropyl methylcellulose has a number average molecular weight of approximately 86,000 dalton, the guar gum is hydroxypropyl guar, and the hyaluronic acid is sodium hyaluronate.

16. The composition of claim 10 further comprising an ingredient selected from the group consisting of pharmaceutically acceptable buffering agents; preservatives; tonicity-adjusting agents; surfactants; solubilizing agents; stabilizing agents; comfort-enhancing agents; emollients; agents; and lubricants.

17. The composition of claim 10 wherein the ophthalmic drug is selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.

18. An aqueous composition suitable for ophthalmic administration comprising: an ophthalmic drug selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents; a preservative; and a viscosity enhancing amount of combination of two polymers having a synergistic effect on the composition's viscosity and wherein the combination of two polymers is selected from the group consisting of hydroxypropyl methylcellulose and guar gum; a carboxyvinyl polymer and guar gum; and hyaluronic acid and guar gum; wherein the total concentration of the two polymers ranges from 0.2-2.0% (w/w); wherein the viscosity of the composition is greater than 150% of the simple sum of two respective single polymer solutions containing only one of the two polymers and wherein the pH of the composition is in the range of 6-8 and wherein the composition is suitable for topical administration.

19. The composition of claim 18 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum.

20. The composition of claim 18 wherein the combination of two polymers is a combination of a carboxyvinyl polymer and guar gum.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc